Daiichi exits combo vaccine pact with Sanofi after pertussis shot manufacturing glitches

As Daiichi Sankyo and Sanofi both chip in on production of other pharmas' COVID-19 shots, the companies are calling it quits on their own, separate vaccine alliance in Japan.

Daiichi Sankyo is axing its marketing pact with Sanofi for its Squarekids combination vaccine and terminating a development deal for the pentavalent combination shot VN-0105 after encountering a manufacturing glitch.